Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The drug combination was safe and showed promise in treating advanced tumors.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Promising cancer treatments were found, but the manufacturer closed.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Method accurately measures finasteride and tamsulosin in combined drug form.

A specific gene variant (rs4833095) is linked to a higher risk of alopecia areata in Koreans.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

TPA is about 50 times more effective at promoting tumors than MZ.